In this issue:
CV events with finerenone in type 2 diabetes and CKD
CV and renal outcomes with efpeglenatide in type 2 diabetes
CV, mortality and renal outcomes with GLP-1 agonists for type 2 diabetes
Macrophage-regulating drug assists diabetic foot ulcer wound healing
Once-weekly exenatide for diabetes care in Indigenous Australians
Trends in emergency DKA admissions before and during COVID-19 pandemic
Type 2 diabetes and changes in total hip bone area and BMD
Incident HF risk in early-onset type 2 diabetes
Impact of frailty on intensive glucose/BP control in type 2 diabetes
Glycaemic worsening in youth vs. adults with impaired glucose tolerance/type 2 diabetes
Please login below to download this issue (PDF)